TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Proportion of children with subnormal FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: adverse side effects score
Endpoint domain: Adverse events/effects
Primary endpoint: No longer required transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Functional Assessment of Chronic Illness Therapy‐Fatigue scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: complete response rates/recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Infants' weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Infants' head circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycemic response time to return to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: capillary refill time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UFS-QoL quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cumulative repeat procedure rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Gastric Workload Units (GWU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of blood stream infection
Endpoint domain: Adverse events/effects
Primary endpoint: Peak velocity of dorsalis pedis artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Reconsultation due to clinical deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in hostility score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-year death rates
Endpoint domain: Mortality/survival
Primary endpoint: time to composite end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major bleeding events or clinically relevant non-major bleeding events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: self-reported stress levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DASS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported confidence in anatomy material
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Development of delayed pneumothorax
Endpoint domain: Adverse events/effects
Primary endpoint: change in abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cavg.ss concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of days undervaccinated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: better psychomotor speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in immunological profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HADS-Anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HADS-Depression score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: QLQ-C30 global health status score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Self-Rating Depression Scale (SDS) score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom Checklist 90 Revised (SCL-90-R) subscore for depression improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Indexed left ventricular end-systolic volume (LVESVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Indexed left ventricular end-diastolic volume (LVEDVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Virological nonsuppression (viral load ≥1,000 copies/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of akathisia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global clinical assessment of akathisia scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in sST2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: posttraumatic stress symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self‐compassionate action
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Geriatric Depression‐15 Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Assessment Scale of Adaptation Difficulty for the Elderly score
Endpoint domain: Life impact
Endpoint subdomain: Adaptation to old age
Primary endpoint: Atrial Fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardioembolic Stroke (CES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tricuspid Regurgitant Jet Velocity (TRJV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Predictive performance of mapping algorithms
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: muscle responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glycogen synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Renographic GFR improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Anastomotic leak (AL) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall remission (ORR)
Endpoint domain: Mortality/survival
Primary endpoint: RUDS posttest score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3 and 4 acute toxic effects
Endpoint domain: Adverse events/effects
Primary endpoint: mean air-bone gap
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone conduction threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of predefined respiratory adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: absolute change in ppFEV1 from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean change in St George's Respiratory Questionnaire (SGRQ) total
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Management of dental caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum FFA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: anhedonia symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: neck flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive urine toxicology for cocaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive urine toxicology for benzodiazepines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PROMIS-Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean intraoperative BG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visceral Fat Area (VFA) of ≥100 cm2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance passed during a two-minute walk test (2MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of intrapartum antibiotic prophylaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of the rapid test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the rapid test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rAI functional connectivity alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: stress-induced cortisol response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Postprocedure cerebrovascular events (stroke and TIA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: MRI-detected asymptomatic cerebrovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean velocity associated with % 1RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge about COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitude towards COVID-19
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Public health practices
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in treatment preferences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Metabolic syndrome (MS) reversibility rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visit adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Weight change across 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of progressive disease
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of antepartum depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Preference for telehealth
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time off work required
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time consumption of telehealth visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Child SPAN SHEI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child fruit and vegetable intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean difference in pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burnout measure (emotional exhaustion)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mindfulness measure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: shoulder pain on arm activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CS (Clinical Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SST (Shoulder Specific Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child consumption of QPM in the past week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: QPM flour stored separately from conventional maize
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Caregivers cooked QPM specifically for young children in the past week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Iodine load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: unmet caregiver support needs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concentrations of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and total n‐3 PUFA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: n‐6:n‐3 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Motor Assessment Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Barthel Index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: End-of-life (EOL) discussions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Missed opportunities for EOL discussions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stress-induced craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress-induced anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CORT/ACTH normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total time for recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost of treatment for injuries
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: N-glycan branching on T and NK cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in VAS and KOOS subscales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative peak closing velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of Motion (ROM) in SLR test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Perceived stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean swing duration (MSWD) in fast walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: persistence of ID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of ID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EXTEM maximum clot firmness upon CPB separation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Congenital malformation rates
Endpoint domain: Adverse events/effects
Primary endpoint: BMD and neurodevelopment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of moderate or severe symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Respiratory symptoms per home dose
Endpoint domain: Adverse events/effects
Primary endpoint: Milk-specific IgE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Fecal Bifidobacterium spp abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: school climate
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Graft flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in CDR-SB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation of anticoagulant therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse skin reactions requiring discontinuation of cECG monitoring
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in guilt
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite end point of cardiovascular death, myocardial infarction, stroke, stent thrombosis, and severe recurrent ischemia
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative PT use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean concentration of total PG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: melatonin onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: melatonin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: phase angle between melatonin onset and sleep bedtime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of endotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oxygen saturation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EF75 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of vasospasm-related morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interest in receiving assistance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FI-C
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Urge to smoke or craving a cigarette
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body awareness
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: displacement during cycles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of offences
Endpoint domain: Adverse events/effects
Primary endpoint: Convictions related to violence
Endpoint domain: Adverse events/effects
Primary endpoint: Convictions related to property offences
Endpoint domain: Adverse events/effects
Primary endpoint: time of invasive ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: physician compassion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: professionalism
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Seizure freedom for 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Readiness for Deprescribing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fibrinogen concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of plasmin generation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clot stability and structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: affective control
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of bedsharing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maternal perception of an infant sleep problem
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Presence of maternal depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: tetravalent seroconversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: set shifting speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional outcome
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: hyperglycemia relapse-free survival
Endpoint domain: Mortality/survival
Primary endpoint: ITAS negative scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test-retest reliability of SSR parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean modeled global-QOL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: pain questionnaire scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of emotional function
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall satisfaction situation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cooperation ability
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Number of metastatic lymph nodes identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Final pathologic TNM stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early decreases in CD19+CD20‐CD138+ long‐lived plasma cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Early increases in overall CD19+CD20+ B cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in anti‐dsDNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of patients with an abnormal ACTH stimulation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Peak torque of musculus flexor and musculus extensor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Absolute error angle of lumbar proprioceptive index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median clinical blockade period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: mean total neuromuscular blockade duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Social capital
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: transfers to the ICU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 24,25(OH)2D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in 1,25(OH)2D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in VMR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes